136 related articles for article (PubMed ID: 29293945)
1. A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
Carcinogenesis; 2018 Mar; 39(3):347-359. PubMed ID: 29293945
[TBL] [Abstract][Full Text] [Related]
2. Lung-specific distant enhancer cis regulates expression of FOXF1 and lncRNA FENDRR.
Szafranski P; Gambin T; Karolak JA; Popek E; Stankiewicz P
Hum Mutat; 2021 Jun; 42(6):694-698. PubMed ID: 33739555
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA
Szafranski P; Stankiewicz P
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513839
[TBL] [Abstract][Full Text] [Related]
5. FENDRR: A pivotal, cancer-related, long non-coding RNA.
Zheng Q; Zhang Q; Yu X; He Y; Guo W
Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
[TBL] [Abstract][Full Text] [Related]
6. Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer.
Yang L; Lu X; Qiu F; Fang W; Zhang L; Huang D; Xie C; Zhong N; Ran P; Zhou Y; Lu J
Eur J Hum Genet; 2015 Aug; 23(8):1019-24. PubMed ID: 25407004
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum to: A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
Carcinogenesis; 2021 Dec; 42(12):1506-1507. PubMed ID: 34942646
[No Abstract] [Full Text] [Related]
8. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
Zhang G; Wang Q; Zhang X; Ding Z; Liu R
Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.
Pan H; Yu T; Sun L; Chai W; Liu X; Yan M
Transl Cancer Res; 2020 Jun; 9(6):3946-3959. PubMed ID: 35117761
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review.
Fazaeli H; Sheikholeslami A; Ghasemian F; Amini E; Sheykhhasan M
Curr Mol Med; 2023 May; 23(7):606-629. PubMed ID: 35579154
[TBL] [Abstract][Full Text] [Related]
11. Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population.
Wang H; Yang L; Deng J; Wang B; Yang X; Yang R; Cheng M; Fang W; Qiu F; Zhang X; Ji W; Ran P; Zhou Y; Lu J
Mutagenesis; 2014 Sep; 29(5):311-7. PubMed ID: 24891316
[TBL] [Abstract][Full Text] [Related]
12. Effects of a functional variant c.353T>C in snai1 on risk of two contextual diseases. Chronic obstructive pulmonary disease and lung cancer.
Yang L; Yang X; Ji W; Deng J; Qiu F; Yang R; Fang W; Zhang L; Huang D; Xie C; Zhang H; Zhong N; Ran P; Zhou Y; Lu J
Am J Respir Crit Care Med; 2014 Jan; 189(2):139-48. PubMed ID: 24354880
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
Gong F; Dong D; Zhang T; Xu W
Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
[TBL] [Abstract][Full Text] [Related]
14. The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.
Lo FY; Chang JW; Chang IS; Chen YJ; Hsu HS; Huang SF; Tsai FY; Jiang SS; Kanteti R; Nandi S; Salgia R; Wang YC
BMC Cancer; 2012 Jun; 12():235. PubMed ID: 22691236
[TBL] [Abstract][Full Text] [Related]
15. The value of lncRNA
Herrera-Merchan A; Cuadros M; Rodriguez MI; Rodriguez S; Torres R; Estecio M; Coira IF; Loidi C; Saiz M; Carmona-Saez P; Medina PP
Oncotarget; 2020 Mar; 11(13):1172-1185. PubMed ID: 32284793
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA FOXF1 adjacent non-coding developmental regulatory RNA inhibits growth and chemotherapy resistance in non-small cell lung cancer.
Xu R; Han Y
Arch Med Sci; 2019 Oct; 15(6):1539-1546. PubMed ID: 31749883
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FENDRR Expression Correlates with Tumor Immunogenicity.
Munteanu MC; Sethuraman SN; Singh MP; Malayer J; Ranjan A
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200642
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer.
Xu W; Wang B; Cai Y; Chen J; Meng E; Guo C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(39):4100-4106. PubMed ID: 34414867
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
[TBL] [Abstract][Full Text] [Related]
20. Fendrr involves in the pathogenesis of cardiac fibrosis via regulating miR-106b/SMAD3 axis.
Gong L; Zhu L; Yang T
Biochem Biophys Res Commun; 2020 Mar; 524(1):169-177. PubMed ID: 31982134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
